David Kirske
Director of Finance/CFO bij CTI BIOPHARMA CORP.
Profiel
David H.
Kirske is currently the CFO, Secretary & Executive Vice President at CTI BioPharma Corp.
He previously held positions as the Chief Financial Officer & Vice President at Helix BioMedix, Inc., Treasurer & Controller at Redhook Ale Brewery, Inc., and Treasurer & Controller at F5, Inc. Mr. Kirske completed his undergraduate degree at the University of Puget Sound.
Actieve functies van David Kirske
| Bedrijven | Functie | Begin |
|---|---|---|
| CTI BIOPHARMA CORP. | Director of Finance/CFO | 26-09-2017 |
Eerdere bekende functies van David Kirske
| Bedrijven | Functie | Einde |
|---|---|---|
| HELIX BIOMEDIX, INC. | Director of Finance/CFO | 23-06-2008 |
| Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - |
| F5, INC. | Comptroller/Controller/Auditor | - |
Opleiding van David Kirske
| University of Puget Sound | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| F5, INC. | Technology Services |
| Bedrijven in privébezit | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Redhook Ale Brewery, Inc. | Consumer Non-Durables |
